Aytu BioPharma Inc (STU:AY20)
€ 2.88 0.04 (1.41%) Market Cap: 16.19 Mil Enterprise Value: 13.39 Mil PE Ratio: 0 PB Ratio: 0.58 GF Score: 33/100

Aytu BioScience Inc at LD Micro Main Event Transcript

Dec 15, 2020 / 07:20PM GMT
Release Date Price: €139
Unidentified Participant

Hello. We have Josh from Aytu BioScience. Aytu BioScience is a commercial stage specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. The company currently markets a portfolio of prescription products addressing large primary care and pediatric markets. If our panelists can go offline, Josh, you have the floor.

Josh Disbrow
Aytu BioScience, Inc, - Chairman & CEO

Great. Thanks very much. Good afternoon, everyone. Good morning, if you're on the West Coast, and thanks for joining us for this presentation. I'll keep this relatively brief just because we are on a relatively constrained timeframe here, but excited to be with you here to share with you some relatively late breaking news with respect to Aytu.

As mentioned, Aytu BioScience is a specialty pharmaceutical company. We are a commercial stage company, and we're focused on acquiring and or licensing assets in both the prescription and the consumer health care markets. We've undergone a significant transformation over the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot